↓ Skip to main content

Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer

Overview of attention for article published in Investigational New Drugs, August 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

patent
5 patents

Readers on

mendeley
51 Mendeley